LHC Group (LHCG) PT Raised to $65 at Jefferies; Reiterates Buy

Jefferies raised its price target on LHC Group (NASDAQ: LHCG) to $65.00 (from $56.00) while maintaining a Buy rating. LHCG reported an EPS beat of $0.53 vs. $0.44 consensus. The beat benefited from robust organic growth and solid expense controls, including G&A as a % of rev declining 160 bps Y/Y and 20 bps Q/ Q.

Analyst Brian Tanquilut is bullish on LHCG given views that it is positioned for EPS upside surprises given its ability to consistently deliver robust organic growth, which Jefferies believes is being driven by its quality differentiation and long-standing hospital relationships.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Walmart (WMT) PT Lowered to $126 at BofA Securities
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'